Respiratory viruses and exacerbations of asthma in adults.

KG Nicholson, J Kent, DC Ireland - British Medical Journal, 1993 - bmj.com
OBJECTIVE--To study the role of respiratory viruses in exacerbations of asthma in adults.
DESIGN--Longitudinal study of 138 adults with asthma. SETTING--Leicestershire Health …

[HTML][HTML] Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

…, DM Fleming, FY Aoki, KG Nicholson… - … England Journal of …, 1997 - Mass Medical Soc
Background The sialic acid analogue zanamivir (GG167) is a selective inhibitor of influenza
A and B virus neuraminidases. These viral enzymes are essential for the release of virus …

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against …

KG Nicholson, AE Colegate, A Podda, I Stephenson… - The Lancet, 2001 - thelancet.com
Background In 1997, pathogenic avian influenza A/Hong Kong/97 (H5N1) viruses emerged
as a pandemic threat to human beings. A non-pathogenic variant, influenza A/Duck/…

Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden

KG Nicholson, J Kent, V Hammersley, E Cancio - Bmj, 1997 - bmj.com
Karl G Nicholson, senior lecturer in infectious diseasesa, … relating to chronic disability; F—relating
to total impairment; G—relating to reproductive impairment resulting in infertility; and H…

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

…, KR Abrams, A Wailoo, D Turner, KG Nicholson - Bmj, 2003 - bmj.com
Objective To review the clinical effectiveness of oseltamivir and zanamivir for the treatment
and prevention of influenza A and B. Design Systematic review and meta-analyses of …

[HTML][HTML] Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine

…, K Hoschler, H Dillon, KG Nicholson… - … England Journal of …, 2009 - Mass Medical Soc
Background The 2009 pandemic influenza A (H1N1) virus has emerged to cause the first
pandemic of the 21st century. Development of effective vaccines is a public health priority. …

[BOOK][B] Textbook of influenza.

KG Nicholson, RG Webster, AJ Hay - 1998 - cabidigitallibrary.org
This book, suitable for students and specialists alike, includes 41 chapters, each written
specifically for the book and divided into 12 sections titled: historical introduction (2 chapters); …

[HTML][HTML] Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD

…, M Medina, S Batham, MR Barer, KG Nicholson… - Chest, 2011 - Elsevier
Background Antibiotic overuse in respiratory illness is common and is associated with drug
resistance and hospital-acquired infection. Biomarkers that can identify bacterial infections …

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) …

I Stephenson, R Bugarini, KG Nicholson… - The Journal of …, 2005 - academic.oup.com
Antigenically well-matched vaccines against highly pathogenic avian influenza H5N1
viruses are urgently required. Human serum samples after immunization with MF59 or …

Reduction in mortality associated with influenza vaccine during 1989-90 epidemic

AH Ahmed, KG Nicholson, JS Nguyen-Van-Tam - The Lancet, 1995 - Elsevier
Influenza epidemics are associated with excess winter mortality. Risk factors for influenza
complications and death include chronic illness and living in residential care. In the UK uptake …